Radiopharm Theranostics Limited (ADR) share price logo

Radiopharm Theranostics Limited (ADR)

NASDAQ: RADX

Small Cap

$4.45

+0.04

(+0.79%)

as on

Radiopharm Theranostics Limited (ADR) Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.30
    $4.54
    downward going graph

    3.37%

    Downside

    2.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.62
    $16.25
    downward going graph

    18.65%

    Downside

    265.17%

    Upside

    downward going graph

Radiopharm Theranostics Limited (ADR) share price movements today

Previous Close
$4.42
Open
$4.35
Volume
147.0K
Day's Low - High
$4.30 - $4.54
52 Week Low - High
$3.62 - $16.25

Radiopharm Theranostics Limited (ADR) Historical Returns

1 Month Return
-4.09 %
3 Month Return
-5.72 %
1 Year Return
-11.88 %
3 Year Return
0 %
5 Year Return
0 %

Radiopharm Theranostics Limited (ADR) Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.8M

EPS (TTM)

-3.285

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-92.10%

Radiopharm Theranostics Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Limited (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$34.8MNANA-286.16%NA
BUY$37.7B57.21%71.2112.55%NA
BUY$116.5B140.42%27.2235.51%NA
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Radiopharm Theranostics Limited (ADR) Stock including INR - Dollar returns

The Radiopharm Theranostics Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Radiopharm Theranostics Limited (ADR) investment value today

Current value as on today

₹95,986

Returns

-₹4,014

(-4.01%)

Returns from Radiopharm Theranostics Limited (ADR) Stock

-₹11,881 (-11.88%)

Dollar Impact

₹7,867 (+7.87%)

Indian Investors' Interest in Radiopharm Theranostics Limited (ADR) Stock

Search interest for Radiopharm Theranostics Limited (ADR) Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Radiopharm Theranostics Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
0
0
3
Gross Profit
0
0
0
0
Operating Income
-19
-34
-36
-38
EBITDA
-17
-31
-44
-38
Interest Expense
9
0
0
0
Depreciation
2
3
3
0
Income Before Tax
-30
-34
-47
-38
Income Tax Expense
0
0
0
0
Net Income
-21
-23
-31
-38
Net Profit Margin
-343550.89%
-11838.59%
-16024.28%
-1055.27%

Radiopharm Theranostics Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Net Income
-
-
-
-
Operating Cash Flow
-4
-7
-13
-8
Investing Cash Flow
-
-
2
0
Financing Cash Flow
5
22
38
-2
Change in Cash
1
15
27
-9

Radiopharm Theranostics Limited (ADR) Annual Cash Flow

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-30
-34
-47
-38
Operating Cash Flow
-9
-23
-22
-36
Investing Cash Flow
-28
-1
0
1
Financing Cash Flow
65
9
30
45
Change in Cash
26
-15
6
10

Global Institutional Holdings in Radiopharm Theranostics Limited (ADR)

Funds
Holdings
Marex Group PLC
0%
Stonepine Capital Management Llc
0%
SILVERARC CAPITAL MANAGEMENT, LLC
2.38%
HSBC Holdings PLC
0.78%
PNC Financial Services Group Inc
0.2%

Insights on Radiopharm Theranostics Limited (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RADX stock has moved up by 4.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 21.0%

About Radiopharm Theranostics Limited (ADR)

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
OrganisationRadiopharm Theranostics Limited (ADR)
Headquarters62 Lygon Street, Carlton, VIC, Australia, 3053
IndustryBiotechnology
CEOMr. Riccardo Canevari
E-voting on sharesClick here to vote

Key Management of Radiopharm Theranostics Limited (ADR)

Name

Title

Mr. Aaron Laurita

Chief Financial Officer

Mr. Hitesh Goel

Head of Project Management

Mr. Nathan Jong C.A.

Joint Company Secretary

Ms. Amritha Sushil

Joint Company Secretary

Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD

Founder & Executive Chairman

Mr. Riccardo Canevari

MD, CEO & Director

Dr. Dimitris Voliotis M.D.

Chief Medical Officer

FAQs

What is Radiopharm Theranostics Limited (ADR) share price today?

Radiopharm Theranostics Limited (ADR) share price today is $4.45 as on at the close of the market. Radiopharm Theranostics Limited (ADR) share today touched a day high of $4.54 and a low of $4.3.

What is the 52 week high and 52 week low for Radiopharm Theranostics Limited (ADR) share?

Radiopharm Theranostics Limited (ADR) share touched a 52 week high of $16.25 on and a 52 week low of $3.62 on . Radiopharm Theranostics Limited (ADR) stock price today i.e. is closed at $4.45,which is 72.62% down from its 52 week high and 22.93% up from its 52 week low.

What is Radiopharm Theranostics Limited (ADR)'s market capitalisation today?

Radiopharm Theranostics Limited (ADR) market capitalisation is $0.00T as on .

How to invest in Radiopharm Theranostics Limited (ADR) Stock (RADX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Radiopharm Theranostics Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Radiopharm Theranostics Limited (ADR) Shares that will get you 0.3371 shares as per Radiopharm Theranostics Limited (ADR) share price of $4.45 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Radiopharm Theranostics Limited (ADR) Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Limited (ADR) (RADX) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Radiopharm Theranostics Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Radiopharm Theranostics Limited (ADR) share’s latest price of $4.45 as on June 19, 2026 at 8:46 am IST, you will get 2.2472 shares of Radiopharm Theranostics Limited (ADR). Learn more about fractional shares .